Literature DB >> 6129424

A coordinated approach to children's health in India: progress report after five years (1975-1980).

.   

Abstract

The success of an experiment in a coordinated approach to children's health care in India in 33 community blocks led to its expansion to a national programme covering 150 community blocks by 1980. The Integrated Child Development Services (ICDS) scheme has also been successful as a national programme. Acceptance of immunisation and nutrition intervention schemes and improvement in nutritional status were significantly higher in the community served through the integrated approach than in the community receiving health, nutrition, and education services separately. Favourable impact of ICDS services was proportionally better in the first year than in the fourth year of the service. The Government of India has declared it a programme of national importance to expand and cover 913 of the 5011 community blocks and 87 urban slum areas by 1985.

Entities:  

Keywords:  Asia; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; Health; Health Services; Immunization--statistics; India; Integrated Programs; Malnutrition; Medicine; Nutrition Disorders--statistics; Nutrition Programs; Organization And Administration; Population; Population Characteristics; Preventive Medicine; Primary Health Care; Program Evaluation; Programs; Public Health; Rural Population; Southern Asia; Urban Population; Vaccination--statistics

Mesh:

Year:  1983        PMID: 6129424

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  2 in total

1.  In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV.

Authors:  A Carr; B Tindall; R Penny; D A Cooper
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

2.  Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection.

Authors:  A Carr; E Vasak; V Munro; R Penny; D A Cooper
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.